Paras Healthcare IPO — GMP Today, Price Band & Dates
Paras Healthcare IPO GMP Today
The current grey market premium (GMP) of the Paras Healthcare IPO is ₹13. GMP reflects unofficial demand for the shares before listing and moves with market sentiment and subscription numbers. This figure updates automatically every hour.
Key Details
| IPO Name | Paras Healthcare |
|---|---|
| Type | Mainboard |
| IPO Dates | 21-23 Oct 2026 |
| Price Band | ₹693 |
| GMP Today | ₹13 |
| Estimated Listing | ₹706 (1.88%) |
| Status | Closed |
Live data last refreshed: 16/11/2026, 17:26:32 IST
FAQ
What is the GMP of Paras Healthcare IPO today?
Paras Healthcare IPO GMP today is ₹13.
What are the Paras Healthcare IPO dates?
Paras Healthcare IPO dates: 21-23 Oct 2026.
Is Paras Healthcare a Mainboard or SME IPO?
Paras Healthcare is a Mainboard IPO.
Does GMP guarantee listing gains?
No. GMP is an unofficial, unregulated indicator and can change quickly. Always evaluate the company's fundamentals before investing.
About Paras Healthcare
Paras Healthcare Limited is a clinical specialty-led healthcare provider offering tertiary and quaternary healthcare services under the 'Paras Health' brand. The company operates a network of eight hospitals across North India, Bihar, and Jharkhand, with its oldest hospital in Gurugram operating for 20 years. As of June 30, 2026, the company had an aggregate bed capacity of 2,211 beds, 1,502 operational beds, and 559 ICU beds. Its network spans Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar, supported by 1,084 doctors and 1,937 nurses.
Business Model
Paras Healthcare operates under a single business segment of healthcare services. It generates revenue primarily through in-patient department (IPD) services, out-patient department (OPD) consultations, and pharmacy sales. In Fiscal 2026, in-patient revenue contributed the majority of operational revenue. The company serves patients across three payor categories: government schemes and public sector undertakings (41.28% of Fiscal 2026 revenue), self-pay patients (33.88%), and insurance/third-party administrators (24.84%).
Financial Performance
| Metric | Fiscal 2024 | Fiscal 2025 | Fiscal 2026 |
|---|---|---|---|
| Revenue from operations | ₹ 11,290.39 million | ₹ 12,940.63 million | ₹ 16,059.52 million |
| EBITDA | ₹ 1,544.11 million | ₹ 1,564.61 million | ₹ 3,355.77 million |
| EBITDA margin (%) | 13.42% | 11.91% | 20.60% |
| Profit / (loss) after tax | ₹ (153.31) million | ₹ (579.83) million | ₹ 438.34 million |
| Net profit margin (%) | (1.33)% | (4.41)% | 2.69% |
| Net worth | ₹ 3,385.08 million | ₹ 2,804.92 million | ₹ 3,949.41 million |
| Total borrowings | ₹ 5,475.33 million | ₹ 7,279.31 million | ₹ 8,541.01 million |
Figures as disclosed in the DRHP/RHP filed with the stock exchange. Source: offer document.
Objects of the Issue
- Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings availed by the Company: ₹ 3,209.00 million
- Investment in subsidiary PMHPL for full or partial repayment/prepayment of its borrowings: ₹ 541.00 million
- Funding general corporate purposes, not exceeding 25% of gross proceeds
Promoters
Dr. Dharminder Kumar Nagar is the Promoter and Managing Director. Associated with the company since 2003, he has over 22 years of healthcare industry experience and holds MBBS and MPhil degrees. He holds 73,519,238 equity shares (72.80% pre-Offer).
Strengths
- One of the largest healthcare providers in North India, Bihar, and Jharkhand with recognized brand presence.
- Strong clinical focus on tertiary and quaternary care, with CONGOR specialties driving 74.70% of Fiscal 2026 revenue.
- Disciplined expansion strategy paired with a capital-efficient and flexible operating model.
- Modern critical care infrastructure including 559 ICU beds and specialized clinical teams.
- Doctor-led management team possessing extensive operational and execution capabilities in healthcare services.
Key Risks
- Incurred consolidated losses of ₹ 153.31 million in Fiscal 2024 and ₹ 579.83 million in Fiscal 2025.
- High attrition rates among doctors and staff, standing at 60.38% in Fiscal 2026 and 66.74% in Fiscal 2025.
- Revenue concentration in North India, with five regional hospitals contributing 66.07% of Fiscal 2026 operational revenue.
- Contingent liabilities constituted 89.55% of the company's net worth as of June 30, 2026.
- Six out of eight hospital facilities operate on leased premises, revenue-share models, or public-private partnerships.
- A promoter group member's name appears in the CIBIL wilful defaulter database.
Points to Weigh
- Turned profitable in Fiscal 2026 with ₹ 438.34 million in PAT after incurring losses across Fiscal 2024 and 2025.
- Directs ₹ 3,750.00 million from issue proceeds toward debt prepayment for the company and its subsidiary PMHPL.
- High exposure to institutional payors, with government schemes and PSUs accounting for 41.28% of Fiscal 2026 revenue.
- High contingent liabilities relative to net worth (89.55% as of June 30, 2026) present a material financial consideration.